Below are several selected presentations and posters which can be downloaded as PDFs.
2019 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference (Orlando, USA)
April 13-17, 2019.
Poster #7: SYROS study – long-term reduction in rate of respiratory function decline in patients with Duchenne Muscular Dystrophy (DMD) treated with idebenone
Poster #9: Consistent long-term effect of idebenone in reducing respiratory function decline in advanced patients with Duchenne Muscular Dystrophy (DMD)
Poster #11: Crossing thresholds and changing rates of respiratory function decline are predictive of clinical outcomes in Duchenne Muscular Dystrophy (DMD)
23rd International Congress of the World Muscle Society - WMS (Mendoza, Argentina)
October 2-6, 2018. Scientific poster presentations.
15th International Congress on Neuromuscular Diseases - ICNMD (Vienna, Austria)
July 6-10, 2018. Scientific poster presentations.
2018 Parent Project Muscular Dystrophy Annual Conference (Scottsdale, Arizona, USA)
June 28-30, 2018. Presentation by Kristina Sjöblom Nygren, CMO
16th International Conference on Duchenne and Becker Muscular Dystrophy (Rome, Italy)
February 16-18, 2018. Referat von Thomas Meier, CEO
American Thoracic Society 113th Annual Conference (Washington, DC)
May 22-23, 2017.
Scientific poster: Correlation between volume- and flow-related pulmonary function outcomes in patients with DMD
Scientific poster: Effect of Idebenone on Bronchopulmonary Adverse Events and Hospitalizations in Patients with Duchenne Muscular Dystrophy (DMD)
EUNOS - 14th Meeting of European Neuro-Ophthalmological Society (Porto, Portugal)
June 16-19, 2019.
Poster P052: Long-term (over 24 months) treatment with idebenone may continue to improve visual function response in patients with Leber’s Hereditary Optic Neuropathy (LHON)
Poster P053: Responder analysis of chronic Leber’s hereditary optic neuropathy (LHON) patients to idebenone in a placebo controlled, randomized clinical trial (RHODOS)
Poster P054: Pediatric Leber’s Hereditary Optic Neuropathy (LHON): Real-world efficacy results following long term idebenone treatment
Poster P055: Evaluating long-term real-world data (RWD) from patients with Leber’s hereditary optic neuropathy (LHON) in light of the recommendations of the International Consensus statement
Poster PAG: A Patient Centric Activity in the Development and Lifecycle of Medicines
NANOS - 45th Annual Meeting of the North-American Neuro-Ophthalmology Society (Las Vegas, USA)
March 16-21, 2019. Scientific poster presentations.
ARVO - Annual Meeting of The Association for Research in Vision and Ophthalmology (Seattle, USA)
May 4, 2016. Poster presentation by Shabir Hasham: Treatment of visual impairment in patients with Leber’s hereditary optic neuropathy using idebenone (Raxone®)
EUNOS - 12th Meeting of European Neuro-Ophthalmological Society (Ljubljana, Slovenia)
June 24, 2015. Presentation by Günther Metz: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy
EVER - Annual Meeting of The European Association for Vision and Eye Research (Nice; France)
October 8, 2015. Poster presentation by Claudia Catarino: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)
Annual North American Cystic Fibrosis Conference - Denver, CO, USA
October 18-20, 2018. Scientific poster: Results From Two Completed Phase I Studies With POL6014-A Novel Inhaled Neutrophil Elastase Inhibitor